Clin2
NCT07319949Possibly a fitNot yet recruiting

Genetic testing to find the origin of metastatic tumors

Malignant Tumor With MetastasisCUP

Part of Cancer clinical trials.

This study looks at your cancer's genetic makeup to help figure out where it originally started. By taking a sample of your metastatic tissue, the research may help guide your treatment decisions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
Any age
Study type
Observational

Who can take part

  • You must have a cancer that has spread from its original spot to another part of the body.
  • A doctor must have confirmed the spread is cancer by examining a tissue sample under a microscope.
  • You need to have a stored piece of the cancer tissue (from surgery or a biopsy) that can be used for extra lab tests.
  • You (or your legal guardian) must be able to sign a form confirming you understand and agree to be in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02215928Recruiting
Using tumor genetic tests to guide treatment choices

This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.

Palo Alto, California
NCT06272864Recruiting
A study looking at genetics of certain advanced cancers

This study tests the genes of your cancer to learn more about advanced breast, lung, melanoma, or sarcoma tumors. It may help doctors find better ways to treat these cancers in the future.

Rogers, Arkansas
NCT06695494Recruiting
Genomic testing for cancer of unknown primary

This trial is for people with cancer of unknown primary (CUP), meaning cancer that started in an unknown place in the body. It aims to use advanced genomic testing (looking at your tumor's DNA) on your stored tumor sample and blood to find clues about where the cancer began and possible treatment options.

Manchester, Greater Manchester
NCT02155621Recruiting
Personalized gene testing to guide cancer treatment choices

This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.

Vancouver, British Columbia
NCT06615830Not yet recruiting
Genetic testing to guide treatment for metastatic pancreatic cancer

This trial uses advanced genetic testing on your tumor sample and lab-grown tumor 'organoids' to help pick treatments that may work better for your metastatic pancreatic cancer. The goal is to find a more personalized treatment plan for you.

NCT03089554Recruiting· Phase 2
Genetic tumor testing to guide targeted cancer treatments

This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.

Lexington, Kentucky

Hear when a new Malignant Tumor With Metastasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.